Blog
Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum
Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum
FEMSA publishes the provisional interim result of the public tender offer for Valora – participation rate of 84.41%
FEMSA publishes the provisional interim result of the public tender offer for Valora – participation rate of 84.41%
Swiss Re expects rise in demand and prices to continue driven by increasing exposures and risk
Swiss Re expects rise in demand and prices to continue driven by increasing exposures and risk
Lonza Appoints Daniel Palmacci as President of the Cell & Gene Division
Lonza Appoints Daniel Palmacci as President of the Cell & Gene Division
DGAP-Adhoc: Major shareholders intend to restructure the board of directors of the SNP SE
DGAP-Adhoc: Major shareholders intend to restructure the board of directors of the SNP SE
DGAP-Adhoc: Epigenomics AG: Capital reduction planned at a ratio of 4 : 1
DGAP-Adhoc: Epigenomics AG: Capital reduction planned at a ratio of 4 : 1
TCS Group Holding PLC announces BOD changes
TCS Group Holding PLC announces BOD changes
Fuller, Smith & Turner PLC: Holding(s) in Company
Fuller, Smith & Turner PLC: Holding(s) in Company
DGAP-Adhoc: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate
DGAP-Adhoc: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate
RM plc: Holding(s) in Company
RM plc: Holding(s) in Company
Leclanché SA: Leclanché announces changes in its Board of Directors
Leclanché SA: Leclanché announces changes in its Board of Directors
OSSIAM US MINIMUM VARIANCE ESG NR UCITS ETF: Amendment of the definition of a business day
OSSIAM US MINIMUM VARIANCE ESG NR UCITS ETF: Amendment of the definition of a business day
Halfords Group PLC: Holding(s) in Company
Halfords Group PLC: Holding(s) in Company
Form 8.3 - The Vanguard Group, Inc.: Vistry Group plc
Form 8.3 - The Vanguard Group, Inc.: Vistry Group plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: Schneider Electric SE
Form 8.3 - The Vanguard Group, Inc.: Schneider Electric SE
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc


